These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16212684)

  • 1. Interpreting patient/informant discrepancies of reported cognitive symptoms in MS.
    Carone DA; Benedict RH; Munschauer FE; Fishman I; Weinstock-Guttman B
    J Int Neuropsychol Soc; 2005 Sep; 11(5):574-83. PubMed ID: 16212684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
    Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B
    Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assessment of cognition in Multiple Sclerosis: the role of personality and anxiety.
    Akbar N; Honarmand K; Feinstein A
    Cogn Behav Neurol; 2011 Sep; 24(3):115-21. PubMed ID: 21904202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting neuropsychological abnormalities in multiple sclerosis.
    Benedict RH; Zivadinov R
    J Neurol Sci; 2006 Jun; 245(1-2):67-72. PubMed ID: 16626751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes.
    O'Brien A; Gaudino-Goering E; Shawaryn M; Komaroff E; Moore NB; DeLuca J
    Arch Clin Neuropsychol; 2007 Nov; 22(8):933-48. PubMed ID: 17851031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awareness of executive functioning deficits in multiple sclerosis: self versus informant ratings of impairment.
    Smith MM; Arnett PA
    J Clin Exp Neuropsychol; 2010 Aug; 32(7):780-7. PubMed ID: 20306356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.
    Morrow SA; Weinstock-Guttman B; Munschauer FE; Hojnacki D; Benedict RH
    Mult Scler; 2009 Aug; 15(8):998-1005. PubMed ID: 19667024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliable screening for neuropsychological impairment in multiple sclerosis.
    Benedict RH; Cox D; Thompson LL; Foley F; Weinstock-Guttman B; Munschauer F
    Mult Scler; 2004 Dec; 10(6):675-8. PubMed ID: 15584493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular size, cognitive function and depression in patients with multiple sclerosis.
    Clark CM; James G; Li D; Oger J; Paty D; Klonoff H
    Can J Neurol Sci; 1992 Aug; 19(3):352-6. PubMed ID: 1393845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-appraised, informant-reported, and objective memory and cognitive function in mild cognitive impairment.
    Chung JC; Man DW
    Dement Geriatr Cogn Disord; 2009; 27(2):187-93. PubMed ID: 19202338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between self-reported executive performance and psychological characteristics in multiple sclerosis.
    van der Hiele K; Spliethoff-Kamminga NG; Ruimschotel RP; Middelkoop HA; Visser LH
    Eur J Neurol; 2012 Apr; 19(4):562-9. PubMed ID: 22008452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive symptoms and fatigue as predictors of objective-subjective discrepancies in cognitive function in multiple sclerosis.
    Hughes AJ; Bhattarai JJ; Paul S; Beier M
    Mult Scler Relat Disord; 2019 May; 30():192-197. PubMed ID: 30797133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Argentina.
    Vanotti S; Benedict RH; Acion L; Cáceres F;
    Mult Scler; 2009 Feb; 15(2):244-50. PubMed ID: 18845653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical atrophy and personality in multiple sclerosis.
    Benedict RH; Hussein S; Englert J; Dwyer MG; Abdelrahman N; Cox JL; Munschauer FE; Weinstock-Guttman B; Zivadinov R
    Neuropsychology; 2008 Jul; 22(4):432-41. PubMed ID: 18590355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of an Internet version of the Multiple Sclerosis Neuropsychological Questionnaire.
    Akbar N; Honarmand K; Kou N; Levine B; Rector N; Feinstein A
    Mult Scler; 2010 Dec; 16(12):1500-6. PubMed ID: 20813773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between global cognitive decline and depressive symptoms in multiple sclerosis.
    Barwick FH; Arnett PA
    Clin Neuropsychol; 2011 Feb; 25(2):193-209. PubMed ID: 21246447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis.
    Christodoulou C; Melville P; Scherl WF; Morgan T; MacAllister WS; Canfora DM; Berry SA; Krupp LB
    J Int Neuropsychol Soc; 2005 Sep; 11(5):614-9. PubMed ID: 16212689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire.
    Benedict RH; Munschauer F; Linn R; Miller C; Murphy E; Foley F; Jacobs L
    Mult Scler; 2003 Feb; 9(1):95-101. PubMed ID: 12617275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
    Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response variability is associated with self-reported cognitive fatigue in multiple sclerosis.
    Bruce JM; Bruce AS; Arnett PA
    Neuropsychology; 2010 Jan; 24(1):77-83. PubMed ID: 20063948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.